Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Geron Corporation (GERN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: GERN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?
Mike Havrilla
•
Oct 29
•
1 Comment
Columbus Day Dash and Slash: DepoMed, Vivus, Oncolytics and RadNet
M. E. Garza
•
Oct 12
•
1 Comment
Stock Watch: BDSI, ACTC.PK, ONTY
VFC's Stock House
•
Oct 11
•
8 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Justin M. Hall
•
Sep 20
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Justin M. Hall
•
Sep 11
•
23 Comments
Megatrend Companies Summary
Bryan Gomez
•
Sep 10
•
10 Comments
More articles on GERN »
Latest Transcript
Geron Corporation Q1 2008 Earnings Call Transcript
Fri May 30, 2008
More transcripts on GERN »
Cramer
Cramer's Lightning Round - Energy Transfer Partners Is an Armored Stock (10/1/09)
Fri October 2, 2009
Cramer's Lightning Round - BAC Is Back (7/27/09)
Tue July 28, 2009
Cramer's Mad Money - Follow That Hedge Fund (5/20/09)
Thu May 21, 2009
More Cramer on GERN »
Instablogs
Friday's Rx-Recap for the Health Care Sector (10-30-09)
Sun November 1, 2009
•
M. E. Garza
•
Comment!
stem cells asleep
Wed October 21, 2009
•
stocknerd
•
Comment!
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern
Fri September 18, 2009
•
Justin M. Hall
•
15 Comments
Write a post on GERN
|
More Instablogs on GERN »
Sentiment
What advice would you give to
GERN?
123 characters left
seekingbeta
: Advice to
GERN
- With large patent estate and inability to move products to market divide the company into a licensing/royalty &
R
&
D
units
Thu, Oct 08, 2009
More advice on GERN »
What's your view of GERN?
Make sure you include GERN
140 characters left
|
Settings